You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifaximin

Showing 1 - 25 of 237
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Decompensated Cirrhosis Trial in Shanghai (Low-dose of Rifaximin, Conventional dose of Rifaximin)

Recruiting
  • Decompensated Cirrhosis
  • Low-dose of Rifaximin
  • Conventional dose of Rifaximin
  • Shanghai, China
    Shanghai East Hospital
May 16, 2023

Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

Not yet recruiting
  • Acute Leukemia
  • Rifaximin with allogeneic stem cell transplant
  • Allogeneic stem cell transplant
  • (no location specified)
Sep 21, 2023

Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV Trial in Guangzhou (Rifaximin 200 mg, Standard Treatment without

Recruiting
  • Liver Failure, Acute on Chronic
  • +5 more
  • Rifaximin 200 mg
  • Standard Treatment without Rifaximin
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
Mar 26, 2023

Crohn Disease, Diabetic Gastroparesis Trial in Jacksonville (Rifaximin, Placebo)

Recruiting
  • Crohn Disease
  • Diabetic Gastroparesis
  • Rifaximin
  • Placebo
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 12, 2022

Healthy Volunteers, Stress, Fear Trial in Leuven (Rifaximin, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • +2 more
  • Rifaximin
  • Placebo
  • Leuven, Belgium
    UZ/KU Leuven
Oct 17, 2022

Sickle Cell Disease Trial in Syracuse (Low Dose Rifaximin ER, Low Dose Rifaximin DER, High Dose Rifaximin ER)

Recruiting
  • Sickle Cell Disease
  • Low Dose Rifaximin ER
  • +4 more
  • Atlanta, Georgia
  • +1 more
Aug 29, 2022

Ascites Infection Trial in Cairo (Rifaximin 550 milligram Oral Tablet [XIFAXAN])

Completed
  • Ascites Infection
  • Rifaximin 550 milligram Oral Tablet [XIFAXAN]
  • Cairo, Egypt
    faculty of medicine Ain Shams university
Nov 17, 2022

Cystic Fibrosis, Abdominal Pain, Small Bowel Disease Trial in Winston-Salem (Rifaximin 550 MG Oral Tablet [XIFAXAN], Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • +2 more
  • Rifaximin 550 MG Oral Tablet [XIFAXAN]
  • Placebo
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jan 19, 2023

Diarrhoea;Acute, Diarrhea Travelers Trial in Djibouti, Comayagua, Nanyuki (Rifaximin 550 MG, Azithromycin 500 MG, Loperamide)

Recruiting
  • Diarrhoea;Acute
  • Diarrhea Travelers
  • Rifaximin 550 MG
  • +2 more
  • Djibouti, Djibouti
  • +2 more
Jan 9, 2023

Irritable Bowel Syndrome With Diarrhea Trial in Karachi (Rifaximin 550 MG, Mebeverine 135 MG, Psyllium Husk)

Active, not recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin 550 MG
  • +3 more
  • Karachi, Sindh, Pakistan
    Bahria University Health Sciences Campus
May 10, 2023

Severe Hepatic Impairment Trial in San Antonio (Rifaximin)

Recruiting
  • Severe Hepatic Impairment
  • Rifaximin
  • San Antonio, Texas
    Valeant Site 01
Sep 7, 2022

Hepatic Encephalopathy Trial in New Orleans (Rifaximin SSD, Placebo)

Recruiting
  • Hepatic Encephalopathy
  • Rifaximin SSD
  • Placebo
  • New Orleans, Louisiana
    Bausch Site 501
Aug 16, 2022

Irritable Bowel Syndrome With Diarrhea Trial in Sadat City (Nitazoxanide 500Mg Oral Tablet, Rifaximin 550Mg Tab)

Recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • Nitazoxanide 500Mg Oral Tablet
  • Rifaximin 550Mg Tab
  • Sadat City, Menoufia, Egypt
    Faculty of Pharmacy, University of Sadat city
Jul 11, 2022

Hepatic Encephalopathy Trial in Palmetto Bay (Rifaximin SSD, Placebo)

Recruiting
  • Hepatic Encephalopathy
  • Rifaximin SSD
  • Placebo
  • Palmetto Bay, Florida
    Bausch Site 001
Apr 7, 2022

Liver Cirrhosis, Renal Failure Trial in New York (Rifaximin, Lactulose)

Withdrawn
  • Liver Cirrhosis
  • Renal Failure
  • New York, New York
    Weill Cornell Medical Center
Jan 24, 2022

Small Intestinal Bacterial Overgrowth, Liver Cirrhosis Trial in Mexico (Rifaximin, Placebo)

Terminated
  • Small Intestinal Bacterial Overgrowth
  • Liver Cirrhosis
  • Rifaximin
  • Placebo
  • Mexico, Ciudad De Mexico, Mexico
    Centro Médico Nacional Siglo XXI
Mar 7, 2022

Alzheimer's Disease Trial in Durham (Rifaximin 550 milligrams (MG))

Completed
Has Results
  • Alzheimer's Disease
  • Rifaximin 550 milligrams (MG)
  • Durham, North Carolina
    Duke University Medical Center
Nov 18, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Best Practice
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

Crohn's Disease Trial in Seattle (Placebo Comparator, Rifaximin)

Completed
  • Crohn's Disease
  • Placebo Comparator
  • Rifaximin
  • Seattle, Washington
    University of Washington Medical Center
Dec 1, 2021

Microbial Colonization Trial in Atlanta (Rifaximin)

Completed
  • Microbial Colonization
  • Rifaximin
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Oct 8, 2021

Chronic Kidney Disease Trial in Kansas City (Rifaximin, Placebo)

Completed
Has Results
  • Chronic Kidney Disease
  • Rifaximin
  • Placebo
  • Kansas City, Kansas
    University of Kansas Medical Center
Oct 8, 2021

Visceral Hypersensitivity, Irritable Bowel Syndrome Trial in Los Angeles (Rifaximin)

Terminated
  • Visceral Hypersensitivity
  • Irritable Bowel Syndrome
  • Rifaximin
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 19, 2021

Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth Trial in Girona (Probiotic, Rifaximin)

Terminated
  • Irritable Bowel Syndrome
  • Small Intestinal Bacterial Overgrowth
  • Probiotic
  • Rifaximin
  • Girona, Spain
    Dr. Bofill Clinic
Nov 2, 2022

Malignant Liver Disease, Major Liver Resection Trial in Aachen (XIFAXAN® (Rifaximin))

Terminated
  • Malignant Liver Disease
  • Major Liver Resection
  • XIFAXAN® (Rifaximin)
  • Aachen, Germany
    RWTH Aachen University
Oct 28, 2021

Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea Trial in Ann Arbor (Rifaximin, Glucose and lactulose hydrogen

Recruiting
  • Irritable Bowel Syndrome
  • Irritable Bowel Syndrome With Diarrhea
  • Rifaximin
  • Glucose and lactulose hydrogen breath testing
  • Ann Arbor, Michigan
    University of Michigan
Dec 1, 2021